Pharnext
Latest round
- Series A
Last raised
- Feb 2012
Total raised
- $19M
Investors
- 6
About Pharnext
Founded in 2007 and based in France, Pharnext SA is a biopharmaceutical company that focuses on developing innovative drug combinations based on genomic big data and artificial intelligence for the treatment of neurological diseases. Its products include PLEODRUG PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A (CMT1A) and PLEODRUG PXT864 for the treatment of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS or Charcot's disease).
Who invested in Pharnext
6 investors across 3 rounds
See all investors in Pharnext
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pharnext
Who invested in Pharnext?
Pharnext has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pharnext raised?
Pharnext has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pharnext last raise money?
Pharnext's most recent round on record is a Series A, in Feb 2012.
What does Pharnext do?
Founded in 2007 and based in France, Pharnext SA is a biopharmaceutical company that focuses on developing innovative drug combinations based on genomic big data and artificial intelligence for the treatment of neurological diseases.
Where is Pharnext headquartered?
Pharnext is headquartered in Paris, France.
Which VCs invest in companies like Pharnext?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Pharnext's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pharnext? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.